MCAID cannabis and driving study
This study is looking at how medical cannabis impacts driving and cognitive performance during the first few months of treatment.
Our research centre has merged
The Centre for Mental Health and Brain Sciences was established in 2023 – merging together the Centre for Mental Health, the Centre for Human Psychopharmacology and the Swinburne Neuroimaging Facility – to lead Swinburne's psychological and neurobiological mental health research.
About this study
This study is looking at how medical cannabis impacts driving and cognitive performance during the first few months of treatment.:
You may be eligible to participate if you:
- have chronic pain
- are 21 years or over
- have a driver’s license
- are about to commence (but have not yet commenced) treatment with medical cannabis
What’s involved?
You will be required to attend Swinburne University in Hawthorn on four separate occasions. The first visit will occur before you use medical cannabis for the first time. The other visits will occur at 4, 8 and 12 weeks after you have started using medical cannabis.
On each of these visits, you will complete a driving simulation task, cognitive assessments and several questionnaires. You will also provide oral fluid samples. You will be reimbursed for your time and medication costs.
For further enquiries
For more information, please email cannidrive@swinburne.edu.au.
Our research ethics and integrity
Our researchers are committed to the highest ethical, professional and scholarly standards. All our studies conform to the Australian Code for the Responsible Conduct of Research, Good Clinical Practice and the National Statement on Ethical Conduct in Human Research.
Explore more from our centre
Contact the Centre for Mental Health and Brain Sciences
We work with academia, industry and government to form meaningful and impactful partnerships. For more information, please email cmhbs@swinburne.edu.au.